News

Two GDP Non-Compliance Reports published in March

Two new GDP Non-Compliance Reports were recently published in the EudraGMDP database – one concerning a wholesale distributor in Cyprus, the other involving a distributor based in Austria.

More
Visit the DHL Vienna Airport Campus

The DHL Vienna Airport Campus is a strategically important logistics hub for Austria and Eastern Europe. As part of the ECA training "GDP for Beginners", participants benefit from an exclusive airport tour, organized in cooperation with DHL. This behind-the-scenes experience offers insights into logistics operations and infrastructure.

More
EMA's 3-Year Work Plan for GMDP Inspectors Working Group: What's Planned for GDP?

The European Medicines Agency (EMA) has published the three-year work plan (2025–2027) of the GMDP Inspectors Working Group, along with the group’s annual report for 2024. In addition to addressing numerous GMP-related topics, both documents also highlight important aspects relevant to the GDP sector. A key focus of the work plan is on ensuring the integrity and resilience of the supply chain.

More
Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 1

Around 60 participants attended the ECA Webinar "GDP Update 2025" in March. Many interesting aspects were discussed in the Q&A session. After the event, the speaker, Dr. Christian Grote-Westrick, answered the submitted questions in writing. We have compiled a selection of these questions and answers for you – read Part 1 here.

More
USP Publishes Summary of Comments on Chapter <1079.2> Regarding Mean Kinetic Temperature (MKT)

The United States Pharmacopeia (USP) has provided responses to stakeholder feedback on the proposed revisions to General Chapter <1079.2>, Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products.

More
EMA: No further Extension of GDP Certificates in 2025

The GMP/GDP Inspectors Working Group decided at the end of 2023 to extend the validity of GDP and GMP certificates that expired at the end of the year until 2024 or until the next on-site inspection, whichever occurs first. It has now been clarified that from 2025, this extension no longer applies.

More
Aide-Mémoires and Checklists in GDP Audits - Benefits and Risks

Aide-mémoires and checklists support a structured approach in GDP audits, ensuring that all relevant aspects are considered. In this article, we examine how these tools can be used effectively, the risks they may entail, and what auditors should pay special attention to.

More
Illegally imported Medicinal Products into Switzerland in 2024: Fewer Shipments, but increasing Risks

Swissmedic, the Swiss authorisation and supervisory authority for drugs and medical products, has provided information on illegal drug imports into Switzerland. In 2024, 5,668 illegal drug imports were seized, representing a 15% decrease in shipments compared to the previous year. However, the danger remains: Illegal products from dubious online sources often contain incorrectly declared, overdosed, or even no active substances at all, posing significant health risks.

More
IPEC: Version 3 of GDP Guide available

In January 2025, version 3 of the IPEC Guide "Good Distribution Practices Guide for Pharmaceutical Excipients" was published on the IPEC website (International Pharmaceutical Excipients Council Europe (IPEC Europe) asbl).

More
MHRA updates Guidance on Sourcing Medicines for the UK Market

The UK Medicines & Healthcare products Regulatory Agency (MHRA) has updated its guidance on sourcing medicines for the UK market. The updates are intended to reflect the new UK-wide licensing arrangements for human medicines from 1 January 2025 as part of the Windsor Framework.

More
x
Search